Embodiments of the disclosure relate to an electroporation device having an improved signal generator for generating high voltage electroporation signals.
Medical devices, such as electroporation devices, require high voltage generators to generate the necessary supply of energy. During the electroporation process, electrodes in contact with the target tissue require electrical power be delivered at a particular voltage and amperage in order to produce the desired electroporation effects (e.g., 200 V at 0.5 Amps). Generally speaking, the high voltage levels required during the electroporation process require a voltage generator that includes a number of high-capacity capacitors. These capacitors, in turn, are very bulky in physical size and require relatively long periods of time to charge before the electroporation process may begin. These attributes are burdensome in handheld units where size and weight are to be kept at a minimum. Furthermore, long charging times can hamper the user's ability to administer the electroporation treatment in a timely and accurate manner. Still further, capacitor-based systems suffer from signal degradation over time
The disclosure provides a signal generator that generates a plurality of lower voltages and combines them in series to create a high voltage.
In one aspect, a handset for use in an electroporation device, the handset including a housing, and a signal amplifier positioned within the housing. Where the signal amplifier includes a primary winding, a plurality of secondary windings coupled together in a series configuration, where a storage capacitor and a fly-back diode are coupled to each of the plurality of secondary windings, and an array having a plurality of electrodes in electrical communication with the signal amplifier.
In another aspect, an electroporation device including a housing, and a signal generator positioned within the housing. The signal generator including a signal amplifier having a primary winding and a plurality of secondary windings coupled together in a series configuration, where a storage capacitor and a fly-back diode are coupled to each of the plurality of secondary windings, a power supply, and a power switch configured to supply a voltage from the power supply across the primary winding, and an array having one or more electrodes in electrical communication with the signal generator.
In still another aspect, an electroporation system including a base station, and a handset removably coupled to the base station. The handset including a housing, an injection assembly, a power supply, and a signal generator positioned within the housing of the handset and in operable communication with the injection assembly. The signal generator including a signal amplifier having a primary winding, and a plurality of secondary windings coupled together in a series configuration, where a storage capacitor and a fly-back diode are coupled to each of the plurality of secondary windings, and a power switch configured to supply a voltage from the power supply across the primary winding, and an array having at least one electrode extending therefrom and in electrical communication with the signal generator.
Before any embodiments of the disclosure are explained in detail, it is to be understood that the disclosure is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the following drawings. The disclosure is capable of other embodiments and of being practiced or of being carried out in various ways.
It should also be noted that a plurality of other structural components may be utilized to implement the disclosure. Furthermore, and as described in subsequent paragraphs, the specific configurations illustrated in the drawings are intended to exemplify embodiments of the disclosure. Alternative configurations are possible.
“Agent” may mean a polypeptide, a polynucleotide, a small molecule, or any combination thereof. The agent may be a recombinant nucleic acid sequence encoding an antibody, a fragment thereof, a variant thereof, or a combination thereof, as detailed in PCT/US2014/070188, which is incorporated herein by reference. “Agent” may mean a composition comprising a polypeptide, a polynucleotide, a small molecule, or any combination thereof. The composition may comprise a recombinant nucleic acid sequence encoding an antibody, a fragment thereof, a variant thereof, or a combination thereof, as detailed in PCT/US2014/070188, which is incorporated herein by reference. The agent may be formulated in water or a buffer, for example. The buffer may be saline-sodium citrate (SSC) or phosphate-buffered saline (PBS), for example. The ionic content of the buffers may increase conductivity, resulting in increased current flow in the targeted tissue. The concentration of the formulated polynucleotide may be between 1 μg and 20 mg/ml. The concentration of the formulated polynucleotide may be 1 μg/ml, 10 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml, 250 μg/ml, 500 μg/ml, 750 μg/ml, 1 mg/ml, 10 mg/ml, 15 mg/ml, or 20 mg/ml, for example.
A “peptide,” “protein,” or “polypeptide” as used herein can mean a linked sequence of amino acids and can be natural, synthetic, or a modification or combination of natural and synthetic.
“Polynucleotide” or “oligonucleotide” or “nucleic acid” as used herein means at least two nucleotides covalently linked together. A polynucleotide can be single stranded or double stranded, or can contain portions of both double stranded and single stranded sequence. The polynucleotide can be DNA, both genomic and cDNA, RNA, or a hybrid. The polynucleotide can contain combinations of deoxyribo- and ribo-nucleotides, and combinations of bases including uracil, adenine, thymine, cytosine, guanine, inosine, xanthine hypoxanthine, isocytosine, isoguanine, and synthetic or non-naturally occurring nucleotides and nucleosides. Polynucleotides may be a vector. Polynucleotides can be obtained by chemical synthesis methods or by recombinant methods.
“Vector” as used herein means a nucleic acid sequence containing an origin of replication. A vector can be a viral vector, bacteriophage, bacterial artificial chromosome, or yeast artificial chromosome. A vector can be a DNA or RNA vector. A vector can be a self-replicating extrachromosomal vector, and preferably, is a DNA plasmid.
The term “electroporation,” (“EP”) as used herein refers to the use of an electric field pulse to induce reversible microscopic pathways (pores) in a bio-membrane; their presence allows agents to pass from one side of the cellular membrane to the other.
The present disclosure relates to a handset 100 for an electroporation device 104 that includes an improved signal generator 32 for producing a predetermined electroporation signal. Illustrated in
Illustrated in
Illustrated in
The electrode array 112 includes a plurality of electrodes 142 each extending outwardly from the front end 128 of the upper portion 124 of the housing 108. Each electrode 142 is in electrical communication with the signal generator 32 and is configured to relay the electroporation signal to the target tissue during operation of the device 104.
In the embodiment illustrated in
First and second outputs 18A-B provide connections between the plurality of secondary windings 14A-E and one or more components that are external to the housing 10. The voltage across the plurality of secondary windings 14A-E is equal to a voltage difference between the first and second outputs 18A-B. For example, when the voltage across the plurality of secondary windings 14A-E is 100 volts, the voltage difference between the first and second outputs 18A-B is 100 volts.
A plurality of electrical components 20 can be coupled to each of the plurality of secondary windings 14A-E. The plurality of electrical components 20 includes, among other components, a storage capacitor 22, a fly-back diode 24, a filtering capacitor 26, and a balancing capacitor 28. In some embodiments, the plurality of electrical components 20 are configured as illustrated in
The plurality of electrical components 20 is disposed within the amplifier housing 10 along with the primary winding 12 and the plurality of secondary windings 14A-E. This configuration enables smaller wire trace lengths between the plurality of electrical components 20 and each of the plurality of secondary windings 14A-E than when compared with components positioned outside of the amplifier housing 10. In addition to permitting a smaller overall footprint for the signal amplifier 5, reducing wire trace lengths reduces the effects of noise (for example, switching noise) on the operation and efficiency of the signal amplifier 5. As such, more accurate and stable electroporation signals may be produced by the handset 100 in a much more compact handset 100.
The above described configuration also enables the use of fewer outputs in the signal amplifier 5. If the plurality of electrical components 20 were outside the amplifier housing 10, each secondary winding would require two outputs. For example, a signal amplifier with five secondary windings would require ten outputs. Disposing the plurality of electrical components 20 within the amplifier housing 10, as illustrated in
The fly-back diode 24 is necessary to achieve a higher voltage output across the secondary winding 14A than the voltage input across the primary winding 12. The voltage difference between the first and second inputs 16A-B induces a current in the primary winding 12 which creates a magnetic field. The secondary winding 14A picks up the magnetic field and creates a voltage/current spike. Energy from this voltage/current spike is stored in the storage capacitor 22 because the fly-back diode 24 prevents the energy from leaking back into the secondary winding 14A. The energy stored in the storage capacitor 22 can only discharge as a DC voltage output across the secondary winding 14A. The filtering capacitor 26 suppresses voltage spikes across the secondary winding 14A that can occur when the voltage across the secondary winding 14A changes suddenly. The balancing capacitor 28 ensures that the voltages across each of the plurality of secondary windings 14A-E are the same value. Use of the balancing capacitor 28 eliminates the need for snubber circuits in the signal amplifier 5.
The physical size of a capacitor is governed by two factors: working voltage and capacitance. The working voltage is the maximum voltage that the capacitor can operate at. The only way to increase the working voltage of a capacitor is to increase the size of the capacitor. Capacitors with high working voltages are fairly large in physical size. Capacitors with small working voltages are smaller in physical size. Conventional high voltage generators require capacitors with high working voltages. Therefore, conventional high voltage generators tend to be larger in physical size. By generating a plurality of lower voltages and combining them in series to create a high voltage, the signal amplifier 5 is smaller in physical size than conventional high voltage generators because the signal amplifier 5 does not require capacitors with high working voltage. Such attributes are desired in a handset 100 which must be held and maneuvered by the user during use.
Capacitors with high working voltages also require more time to completely charge and discharge. By generating a plurality of lower voltages and combining them in series to create a high voltage, the signal amplifier 5 provides high voltages significantly faster than conventional high voltage generators.
Further, conventional high voltage generators used in medical devices (for example, electroporation pulse generators) that include capacitors with high working voltages present an electrocution safety issue for users of the medical devices. The capacitors in conventional high voltage generators must be charged to high voltages before treatment begins and are capable of producing a high output voltage. During the time in which the capacitors are charged at high voltages but the electroporation pulse has not yet been administered, the capacitors are holding a large amount of electrical energy. This large amount of electrical energy is capable of inflicting serious harm on the users of the medical devices if they are electrocuted by the medical devices. In addition, the large amount of electrical energy can cause conventional high voltage generators to explode. By generating a plurality of lower voltages and combining them in series to create a high voltage, the signal amplifier 5 does not need to store a large amount of electrical energy. Therefore, the electrocution safety issue present in conventional high voltage generators is not present with the signal amplifier 5.
In some embodiments, as illustrated in FIG.1, the signal amplifier 5 includes a thermistor 30. The thermistor is a type of resistor whose resistance is dependent on temperature. In some embodiments, a very small duty cycle is used with the signal amplifier 5. This small duty cycle may be greater than the DC rating of the signal amplifier 5. A control circuit (not shown) can be used to ensure that the signal amplifier 5 does not exceed any component rating by monitoring the thermistor 30. In some embodiments, as illustrated in
The power supply 34 supplies a nominal or pulsed DC voltage to the voltage amplifier 5. In the illustrated embodiment, the power supply 34 is powered by one or more batteries or battery packs. In other embodiments, the power supply 34 is powered by mains power having nominal line voltages between, for example, 100V and 240V AC and frequencies of approximately 50-60 Hz. In other embodiments, the power supply 34 is powered by a combination of battery power and mains power. In some embodiments, the power supply 34 is powered by USB (i.e., Universal Serial Bus) power having a nominal line voltage of 5V. In some embodiments, the batteries are a type of rechargeable battery. Rechargeable batteries include, for example, lithium-ion, lead-acid, nickel cadmium, nickel metal hydride, etc. Lithium-ion batteries are smaller and lighter than conventional lead-acid batteries.
The power switch 36 regulates the flow of energy from the power supply 34 to signal amplifier 5. The power switch is electrically coupled to the signal amplifier 5 via the first and second inputs 16A-B. The voltage difference between the first and second inputs 16A-B is based on the ON versus OFF time (i.e., the duty cycle) of the power switch 36. In some embodiments, the power switch 36 includes a switching field-effect transistor (FET).
Thus, the disclosure provides, among other things, a signal amplifier and a signal generator. Various features and advantages of the disclosure are set forth in the following claims.
For reasons of completeness, various aspects of the invention are set out in the following numbered clauses:
Clause 1. A handset for use in an electroporation device, the handset comprising:
a housing;
a signal amplifier positioned within the housing, the signal amplifier including:
an array having a plurality of electrodes in electrical communication with the signal amplifier.
Clause 2. The handset of clause 1, wherein a turn ratio between the primary winding and each of the plurality of secondary windings is one to one.
Clause 3. The handset of clause 1, wherein each fly-back diode and storage capacitor are coupled to a respective one of the plurality of secondary windings in a series configuration.
Clause 4. The handset of clause 1, wherein the fly-back diode and the storage capacitor are coupled to each of the plurality of secondary windings in a parallel configuration.
Clause 5. The handset of clause 4, wherein a filtering capacitor is coupled in a parallel configuration with the storage capacitor.
Clause 6. The handset of clause 5, wherein a balancing capacitor is coupled to each of the plurality of secondary windings in a parallel configuration.
Clause 7. The handset of clause 6, wherein a thermistor is coupled between the plurality of secondary windings and the primary winding.
Clause 8. The handset of clause 1, wherein the plurality of secondary windings includes at least five secondary windings.
Clause 9. The handset of clause 1, wherein the primary winding, the plurality of secondary windings, the storage capacitor and the fly-back diode are each disposed within a signal generator housing.
Clause 10. An electroporation device comprising:
a housing;
a signal generator positioned within the housing including:
an array having one or more electrodes in electrical communication with the signal generator.
Clause 11. The electroporation device of clause 10, wherein a turn ratio between the primary winding and each of the plurality of secondary windings is one to one.
Clause 12. The electroporation device of clause 10, wherein the power supply includes a rechargeable battery.
Clause 13. The electroporation device of clause 12, wherein the rechargeable battery includes a lithium-ion battery.
Clause 14. The electroporation device of clause 10, wherein the fly-back diode and the storage capacitor are coupled to each other in a series configuration.
Clause 15. The electroporation device of clause 14, wherein the fly-back diode and the storage capacitor are coupled to each of the plurality of secondary windings in a parallel configuration.
Clause 16. The electroporation device of clause 15, wherein a filtering capacitor is coupled in a parallel configuration with the storage capacitor.
Clause 17. The electroporation device of clause 10, wherein a balancing capacitor is coupled to each of the plurality of secondary windings in a parallel configuration.
Clause 18. The electroporation device of clause 10, wherein a thermistor is coupled between the plurality of secondary windings and the primary winding.
Clause 19. An electroporation system comprising:
a base station; and
a handset removably coupled to the base station, the handset including:
Clause 20. The electroporation system of clause 19, wherein the base station is in electrical communication with the power supply when the base station is coupled to the handset.
This patent application claims priority to U.S. Provisional Patent Application No. 62/271,955, filed Dec. 28, 2015. The above referenced application is hereby incorporated by reference.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US16/68940 | 12/28/2016 | WO | 00 |
Number | Date | Country | |
---|---|---|---|
62271955 | Dec 2015 | US |